{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:48:25Z","timestamp":1775857705115,"version":"3.50.1"},"reference-count":70,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.14868","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:23:23Z","timestamp":1736231003000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta\u2011analysis"],"prefix":"10.3892","volume":"29","author":[{"given":"Wangyi","family":"Xuan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Ningbo Zhenhai Hospital of Traditional Chinese Medicine, Ningbo, Zhejiang 315299, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Fang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital of Zhejiang People's Armed Police, Hangzhou, Zhejiang 310051, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Xiang","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Stomatology, Zhejiang University of Chinese Medicine, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Stomatology, Zhejiang University of Chinese Medicine, Hangzhou, Zhejiang 310053, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"key20250207091858_b1-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20250207091858_b2-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fonc.2020.00171","article-title":"Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Front Oncol"},{"key":"key20250207091858_b3-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.hbpd.2023.10.009","article-title":"Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives","volume":"23","author":"Gavriilidis","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20250207091858_b4-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"147","DOI":"10.14218\/JCTH.2021.00179","article-title":"Treatments of hepatocellular carcinoma with portal vein tumor thrombus: Current status and controversy","volume":"10","author":"Deng","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"key20250207091858_b5-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000523997","article-title":"Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 edition)","volume":"11","author":"Sun","year":"2022","journal-title":"Liver Cancer"},{"key":"key20250207091858_b6-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/JHC.S318070","article-title":"Portal vein tumor thrombosis and hepatocellular carcinoma-the changing tides","volume":"8","author":"Khan","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"key20250207091858_b7-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.18632\/oncotarget.12817","article-title":"Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 Edition","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"key20250207091858_b8-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"key20250207091858_b9-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000343875","article-title":"JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 Update by the liver cancer study group of Japan","volume":"3","author":"Kudo","year":"2014","journal-title":"Liver Cancer"},{"key":"key20250207091858_b10-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"93258","DOI":"10.18632\/oncotarget.18735","article-title":"Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona clinic liver cancer treatment algorithms: A review and update","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"key20250207091858_b11-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/hepr.12923","article-title":"Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus","volume":"47","author":"Sakamoto","year":"2017","journal-title":"Hepatol Res"},{"key":"key20250207091858_b12-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"709","DOI":"10.21037\/hbsn-20-854","article-title":"Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: A systematic review","volume":"11","author":"Wei","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"key20250207091858_b13-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jceh.2021.04.003","article-title":"New developments in the treatment of hepatocellular carcinoma: The concept of adjuvant and neoadjuvant chemotherapy","volume":"11","author":"Anand","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"key20250207091858_b14-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.jhep.2020.05.048","article-title":"Preoperative immunotherapy for resectable hepatocellular carcinoma: Toward a paradigm shift?","volume":"73","author":"Seckler","year":"2020","journal-title":"J Hepatol"},{"key":"key20250207091858_b15-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20250207091858_b16-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/medicina59122174","article-title":"Efficacy of transarterial chemoembolization (TACE) for early-stage hepatocellular carcinoma","volume":"59","author":"Lee","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"key20250207091858_b17-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4240\/wjgs.v13.i12.1550","article-title":"Neoadjuvant treatment strategies for hepatocellular carcinoma","volume":"13","author":"Xu","year":"2021","journal-title":"World J Gastrointest Surg"},{"key":"key20250207091858_b18-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000521827","article-title":"Surgical resection is preferred in selected solitary hepatocellular carcinoma with portal vein tumor thrombosis","volume":"39","author":"Yang","year":"2022","journal-title":"Dig Surg"},{"key":"key20250207091858_b19-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key20250207091858_b20-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"key20250207091858_b21-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key20250207091858_b22-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5114\/ceji.2023.134257","article-title":"Efficacy of IL-23 inhibitors and IL-12\/23 inhibitors in the induction treatment of Crohn's disease: A meta-analysis based on randomized controlled trials","volume":"48","author":"Gao","year":"2023","journal-title":"Cent Eur J Immunol"},{"key":"key20250207091858_b23-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000535297","article-title":"Association between BMI and efficacy of SGLT2 inhibitors in patients with heart failure or at risk of heart failure: A meta-analysis based on randomized controlled trials","volume":"149","author":"Zhou","year":"2024","journal-title":"Cardiology"},{"key":"key20250207091858_b24-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12893-024-02535-8","article-title":"The safety of not implementing endoscopic nasobiliary drainage after elective clearance of choledocholithiasis: A systematic review and meta-analysis","volume":"24","author":"Yin","year":"2024","journal-title":"BMC Surg"},{"key":"key20250207091858_b25-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1200\/JCO.18.02184","article-title":"Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: A randomized, open-label, multicenter controlled study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20250207091858_b26-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1223632","DOI":"10.3389\/fphar.2023.1223632","article-title":"Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"14","author":"Hu","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20250207091858_b27-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10147-007-0701-y","article-title":"Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma","volume":"12","author":"Kamiyama","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"key20250207091858_b28-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.hpb.2016.04.003","article-title":"Hepatocellular carcinoma with main portal vein tumor thrombus: A comparative study comparing hepatectomy with or without neoadjuvant radiotherapy","volume":"18","author":"Li","year":"2016","journal-title":"HPB (Oxford)"},{"key":"key20250207091858_b29-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s00330-015-4021-8","article-title":"Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: A prospective comparative study","volume":"26","author":"Zhang","year":"2016","journal-title":"Eur Radiol"},{"key":"key20250207091858_b30-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1245\/s10434-018-6653-9","article-title":"Downstaging with localized concurrent chemoradiotherapy can identify optimal surgical candidates in hepatocellular carcinoma with portal vein tumor thrombus","volume":"25","author":"Chong","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"key20250207091858_b31-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","article-title":"Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD","volume":"42","author":"Durand","year":"2005","journal-title":"J Hepatol"},{"key":"key20250207091858_b32-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2024.01.010","article-title":"Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal","volume":"80","author":"Trevisani","year":"2024","journal-title":"J Hepatol"},{"key":"key20250207091858_b33-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/cncr.23878","article-title":"A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: Implication for patient selection in systemic therapy trials","volume":"113","author":"Yau","year":"2008","journal-title":"Cancer"},{"key":"key20250207091858_b34-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000515554","article-title":"Comparison of surgical resection and systemic treatment for hepatocellular carcinoma with vascular invasion: National cancer database analysis","volume":"10","author":"Govalan","year":"2021","journal-title":"Liver Cancer"},{"key":"key20250207091858_b35-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"key20250207091858_b36-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000449336","article-title":"Surgery for intermediate and advanced hepatocellular carcinoma: A consensus report from the 5th Asia-Pacific primary liver cancer expert meeting (APPLE 2014)","volume":"5","author":"Ho","year":"2016","journal-title":"Liver Cancer"},{"key":"key20250207091858_b37-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: Is it adherent to the EASL\/AASLD recommendations?: An observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"key":"key20250207091858_b38-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"65","author":"Kokudo","year":"2016","journal-title":"J Hepatol"},{"key":"key20250207091858_b39-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"40816","DOI":"10.18632\/oncotarget.8386","article-title":"Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus-Eastern hepatobiliary surgical hospital consensus statement","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"key20250207091858_b40-ol-29-3-14868","first-page":"S30","article-title":"Surgical treatment of hepatocellular carcinoma","volume":"33","author":"V\u00e1clav","year":"2020","journal-title":"Klin Onkol"},{"key":"key20250207091858_b41-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"779","DOI":"10.9738\/INTSURG-D-13-00122.1","article-title":"Current and future challenges in the surgical treatment of hepatocellular carcinoma: A review","volume":"99","author":"Tsoulfas","year":"2014","journal-title":"Int Surg"},{"key":"key20250207091858_b42-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.3748\/wjg.14.3452","article-title":"Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease","volume":"14","author":"Delis","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20250207091858_b43-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1072-7515(00)00740-7","article-title":"Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis","volume":"191","author":"Ohkubo","year":"2000","journal-title":"J Am Coll Surg"},{"key":"key20250207091858_b44-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12893-023-02291-1","article-title":"Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3\/4 PVTT following combination therapy of TKIs and PD-1 inhibitors","volume":"23","author":"Jiao","year":"2023","journal-title":"BMC Surg"},{"key":"key20250207091858_b45-ol-29-3-14868","first-page":"391","article-title":"Current status of multimodal & combination therapy for hepatocellular carcinoma","volume":"136","author":"Yang","year":"2012","journal-title":"Indian J Med Res"},{"key":"key20250207091858_b46-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.sla.0000133123.11932.19","article-title":"Salvage surgery following downstaging of unresectable hepatocellular carcinoma","volume":"240","author":"Lau","year":"2004","journal-title":"Ann Surg"},{"key":"key20250207091858_b47-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11739-008-0128-0","article-title":"Portal vein thrombosis in liver cirrhosis","volume":"3","author":"Fimognari","year":"2008","journal-title":"Intern Emerg Med"},{"key":"key20250207091858_b48-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.3748\/wjg.v22.i30.6851","article-title":"Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"Yu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20250207091858_b49-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4143\/crt.2014.276","article-title":"Clinical benefit of hepatic arterial infusion concurrent chemoradiotherapy in locally advanced hepatocellular carcinoma: A propensity score matching analysis","volume":"48","author":"Yoon","year":"2016","journal-title":"Cancer Res Treat"},{"key":"key20250207091858_b50-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-230X-14-84","article-title":"Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: Propensity score analysis","volume":"14","author":"Nakazawa","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"key20250207091858_b51-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.3748\/wjg.v21.i48.13490","article-title":"Comparison of percutaneous radiofrequency ablation and CyberKnife(\u00ae) for initial solitary hepatocellular carcinoma: A pilot study","volume":"21","author":"Shiozawa","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20250207091858_b52-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijsu.2017.06.082","article-title":"Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study","volume":"44","author":"Hamaoka","year":"2017","journal-title":"Int J Surg"},{"key":"key20250207091858_b53-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/jamasurg.2022.4702","article-title":"Phase 2 evaluation of neoadjuvant intensity-modulated radiotherapy in centrally located hepatocellular carcinoma: A nonrandomized controlled trial","volume":"157","author":"Wu","year":"2022","journal-title":"JAMA Surg"},{"key":"key20250207091858_b54-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"8165","DOI":"10.3390\/ijms21218165","article-title":"Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20250207091858_b55-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"101460","DOI":"10.1016\/j.clinre.2020.05.008","article-title":"Comprehensive predictive factors for CalliSpheres\u00ae microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients","volume":"45","author":"Chen","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20250207091858_b56-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1007\/s12032-011-0145-0","article-title":"Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: Using a new classification","volume":"29","author":"Niu","year":"2012","journal-title":"Med Oncol"},{"key":"key20250207091858_b57-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3350\/cmh.2022.0391","article-title":"Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity","volume":"29","author":"Iwamoto","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"key20250207091858_b58-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12885-018-4519-y","article-title":"Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial","volume":"18","author":"Hatooka","year":"2018","journal-title":"BMC Cancer"},{"key":"key20250207091858_b59-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20250207091858_b60-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00423-005-0552-9","article-title":"Surgical treatment of hepatocellular carcinoma in China: Surgical techniques, indications, and outcomes","volume":"390","author":"Chen","year":"2005","journal-title":"Langenbecks Arch Surg"},{"key":"key20250207091858_b61-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/bjs.4413","article-title":"Chinese experience with hepatectomy for huge hepatocellular carcinoma","volume":"91","author":"Chen","year":"2004","journal-title":"Br J Surg"},{"key":"key20250207091858_b62-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2006-941442","article-title":"Complications of hepatic chemoembolization","volume":"23","author":"Clark","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"key20250207091858_b63-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/SLA.0b013e3181961c16","article-title":"A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma","volume":"249","author":"Zhou","year":"2009","journal-title":"Ann Surg"},{"key":"key20250207091858_b64-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.7150\/jca.94539","article-title":"Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study","volume":"15","author":"Wu","year":"2024","journal-title":"J Cancer"},{"key":"key20250207091858_b65-ol-29-3-14868","first-page":"889","article-title":"Which is the best combination of surgery for hepatocellular carcinoma with hepatic\/portal vein thrombosis in China: A network meta-analysis of randomized controlled trials","volume":"26","author":"Wu","year":"2021","journal-title":"J BUON"},{"key":"key20250207091858_b66-ol-29-3-14868","first-page":"1950","article-title":"Comparing the efficacy and safety of local-regional treatments for hepatocellular carcinoma with portal\/hepatic vein tumor thrombosis in China: A network meta-analysis of randomized controlled trials","volume":"26","author":"Wu","year":"2021","journal-title":"J BUON"},{"key":"key20250207091858_b67-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"1344798","DOI":"10.3389\/fonc.2024.1344798","article-title":"Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: Patient-level network meta-analysis","volume":"14","author":"Leung","year":"2024","journal-title":"Front Oncol"},{"key":"key20250207091858_b68-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"106753","DOI":"10.1016\/j.ijsu.2022.106753","article-title":"Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis","volume":"104","author":"Lee","year":"2022","journal-title":"Int J Surg"},{"key":"key20250207091858_b69-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"7289","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016","volume":"22","author":"Chan","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20250207091858_b70-ol-29-3-14868","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S2468-1253(19)30178-5","article-title":"Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: Comparing east and west","volume":"4","author":"Lu","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:19:03Z","timestamp":1738912743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.14868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,1,7]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.14868","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"122"}}